GLP-1 medications affect how your body processes food and beverages, and many patients find their alcohol tolerance decreases significantly
A diagnosis of PA first requires demonstration of megaloblastic anemia by conducting a full blood count and blood smear, which evaluates the mean corpuscular volume (MCV), as well the mean corpuscular hemoglobin concentration (MCHC)
By using AI to analyze more than 400,000 Reddit posts, researchers at Penns School of Engineering and Applied Science have identified patient-reported symptoms associated with GLP-1s, the popular weight-loss and diabetes drugs semaglutide and tirzepatide, that may not be fully captured in clinical trials or regulatory documents
You should seek urgent medical advice if you experience: Severe or persistent abdominal pain, which may indicate pancreatitis Persistent vomiting or diarrhoea leading to dehydration Severe headache or visual disturbance, which may suggest pituitary pathology Visual deterioration in the context of diabetes (possible retinopathy) You should also seek medical advice promptly if you: Are currently using or considering using unregulated peptides and experience unexpected symptoms Have noticed unexplained weight changes, fatigue, or hormonal symptoms Are managing a chronic condition such as diabetes, cardiovascular disease, or a hormone-related disorder Have purchased peptides online and are uncertain about their contents or safety Engaging with a qualified healthcare professional whether a GP, endocrinologist, or registered dietitian ensures that any intervention is tailored to your individual health needs, monitored appropriately, and aligned with current evidence
